Intel to use 'big data' to battle Parkinson's disease

Intel headquarters on January 16, 2014 in Santa Clara, California

US computing giant Intel announced Wednesday it was joining an effort to battle Parkinson's disease with new big data and wearable technologies to improve research and treatment.

Intel said it would work with the Michael J. Fox Foundation for Parkinson's Research—created by the "Back to the Future" Canadian-American actor—on the effort to fight the neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence.

The research will use "a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms," an Intel statement said.

"This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in ."

The statement added that by collecting and analyzing data from thousands of individuals, such as slowness of movement, tremor and sleep quality, researchers can get a better picture of the progression of the disease.

The research will use wearables that "can unobtrusively gather and transmit objective, experiential data in real time, 24 hours a day, seven days a week," according to the statement.

"Nearly 200 years after Parkinson's disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson's disease largely the same way doctors did then," said Todd Sherer, chief executive of the foundation.

"Data science and hold the potential to transform our ability to capture and objectively measure patients' actual experience of disease, with unprecedented implications for Parkinson's drug development, diagnosis and treatment."

add to favorites email to friend print save as pdf

Related Stories

Researchers investigating genetics of Parkinson's disease

Mar 11, 2014

(Medical Xpress)—Researchers at Emory University School of Medicine will study individuals with genetic mutations associated with Parkinson's disease (PD) as part of the Parkinson's Progression Markers Initiative (PPMI), ...

Recommended for you

Parkinson's disease reverted at a experimental stage

21 hours ago

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide. The experiments ...

EU team launches clinical trial of Parkinson's vaccine

Dec 09, 2014

Today the EU-consortium SYMPATH starts recruitment for a Phase I study of a Parkinson's vaccine candidate called AFFITOPE PD03A. This vaccine is one out of a designated pool of promising vaccine candidates based on AFFiRiS' ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.